No impact of increasing symptom burden on quality of life? – Longitudinal data from the German MaLife-Project on patients receiving monochemo- and endocrine treatment for metastatic breast cancer. 7. Juni 2015 Marschner, N., Nusch, A., Decker, T., Münz, M., Kruggel, L., Jänicke, M., 2015. Oncol Res Treat 38 (suppl 5)(V670), 202. doi:10.1159/00043907 Abstract Survival data from patients with advanced or metastatic renal cell carcinoma in routine practice differs significantly from clinical trial data – Analyses from the German clinical RCC Registry. Marschner, N., Müller, L., Staehler, M., Nusch, A., Münz, M., Koska, M., Jänicke, M., Goebell, P., 2015. Oncol Res Treat 38 (suppl.5)(V674), 204. doi:10.1159/000439070… Weiterlesen No impact of increasing symptoms on quality of life? Longitudinal data from the German MALIFE-Project on patients receiving monochemo- and endocrine treatment for advanced breast cancer – results from the TMK registry group. Marschner, N., Nusch, A., Decker, T., Münz, M., Kruggel, L., Jänicke, M., 2015. The Breast 24 (suppl3) (OR51), 39. doi:10.1016/S0960-9776(15)30063-1… Weiterlesen